Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Services (Manufacturing, Packaging Labeling & Blinding, Logistics & Distribution, Storage & Retention, Comparator Sourcing, Other), By Type (Small Molecule Drugs, Biologics Drugs, Medical Devices), By Therapeutic Areas ( Oncology, CNS and Mental Disorders Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Blood Disorders, Immunology and Other Therapeutic Disorder), By End User (Pharmaceutical, Biotechnology Companies, Contract Research Organizations (CROs)), By Region and Competition

The global clinical trial supplies market is anticipated to observe impressive growth during the forecast period, 2024-2028, owing to the growing number of registered clinical trials. Factors such as increased research and development activities, globalization of clinical trials, complexity of study designs, and stringent regulatory requirements have risen the demand for clinical trial supplies in the market.

Clinical trials are an essential component of the drug development process, enabling researchers and pharmaceutical companies to evaluate the safety and efficacy of new treatments and therapies. As more innovative drugs and therapies enter the development pipeline, the need for adequate supplies to support these trials has significantly increased.

Growing Research & Development

A remarkable expansion in medical research and development activities can be observed across the world. With advancements in technology and an increasing understanding of complex diseases, there has been a surge in the number of clinical trials being conducted across various therapeutic areas, such as oncology, neurology, cardiology, and infectious diseases. According to the US National Library of Medicine's clinical data, a total of 68,272 studies are found for cardiology. As a result, the demand for trial supplies, including investigational drugs, medical devices, and diagnostic tools, has correspondingly risen.

Furthermore, the globalization of clinical trials has played a significant role in driving the demand for supplies. Pharmaceutical companies and research organizations are increasingly conducting trials in multiple countries to access diverse patient populations and gain regulatory approvals in various regions. This trend has created a need for clinical trial supplies to be distributed across different geographical locations, ensuring that each trial site has access to the necessary resources.

Increasing Advancement of Clinical Trials

Modern clinical trials often involve sophisticated protocols, innovative study designs, and personalized medicine approaches. These advancements require specialized supplies and technologies, such as biomarkers, genetic testing kits, specialized packaging, and temperature-controlled storage and transport systems. As a result, the demand for these specialized supplies has risen to accommodate the evolving needs of clinical trial designs. Modern clinical trials often involve complex study designs, such as adaptive trials, biomarker-driven trials, and personalized medicine approaches. Based on the clinical trial data by the US National Library of Medicine, 1,843 studies have been performed related to predictive markers. The demand for these specialized supplies has grown as researchers strive to capture more accurate and comprehensive data during clinical trials.

Rising Regulatory Requirements to Ensure Patient Safety

Moreover, regulatory requirements have become more stringent to ensure patient safety and data integrity in clinical trials. Regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented rigorous guidelines for the storage, handling, and documentation of clinical trial supplies. The European Medicines Agency (EMA) focuses its decisions about the approval of medicines on the findings of clinical trials conducted by pharmaceutical companies. Although clinical trials in the European Union (EU) are authorized at the national level, EMA is crucial as cutting-edge clinical trials and to the maintenance of IT systems for the coordination of clinical trials. This has led to an increased demand for supplies that meet regulatory compliance, such as Good Manufacturing Practices (GMP) and Good Clinical Practices (GCP). Pharmaceutical companies and contract research organizations (CROs) must source high-quality supplies that adhere to these standards, further driving the demand for clinical trial materials.

Regulatory authorities have implemented increasingly rigorous guidelines to ensure patient safety, data integrity, and compliance in clinical trials. Pharmaceutical companies and contract research organizations (CROs) ensure they obtain high-quality supplies that meet regulatory standards.

To meet the growing demand for clinical trial supplies, various stakeholders in the pharmaceutical industry have ramped up their manufacturing capabilities and supply chain infrastructure. Pharmaceutical companies, CROs, and specialized suppliers are expanding their production capacities, enhancing their logistics capabilities, and optimizing their distribution networks. Additionally, advancements in digital technologies, such as supply chain management systems and real-time tracking, have improved the efficiency and traceability of clinical trial supplies.

Growing Number of Clinical Trials

Clinical trials are crucial for advancing medical knowledge, evaluating new treatments and therapies, and improving patient care. The rising number of registered trials reflects the growing interest in medical research, the development of innovative therapies, and the recognition of the importance of evidence-based medicine. According to the United States National Library of Medicine, there are currently a total of 452,604 studies registered in Clinicaltrials.gov, with locations in all 50 states and 221 countries around the globe. One of the primary reasons for the increased number of registered clinical trials is the rapid advancement of medical science and technology. The discovery of new disease targets, improved understanding of molecular mechanisms, and breakthroughs in areas like genomics, immunology, and regenerative medicine have opened new avenues for research. This has generated a surge in the development of novel therapies and interventions, leading to a greater need for clinical trials to evaluate their safety and effectiveness.

Additionally, there is a growing awareness among healthcare professionals, researchers, and the public about the importance of evidence-based medicine. Clinical trials provide a rigorous and systematic approach to evaluate the efficacy and safety of medical interventions. As the demand for evidence-based medicine continues to rise, more researchers and institutions are conducting clinical trials to generate high-quality data that can guide medical decision-making and improve patient outcomes. Furthermore, the globalization of clinical research has also contributed to the increased number of registered trials. In the past, clinical trials were predominantly conducted in developed countries. However, there has been a significant shift towards conducting trials in diverse geographic locations, including emerging markets and developing countries. According to clinicaltrials.gov, as of May 17, 2023, the total number of Registered Studies is 140,268, whereas in recent times there are around 240,844 registered studies in non-US locations. This expansion is driven by several factors, such as access to larger patient populations, diverse genetic backgrounds, reduced costs, and expedited regulatory pathways. As a result, there has been a proliferation of clinical trials being registered in regions that were previously understated in medical research.

Rising Demand for Biologics

Advances in biotechnology have revolutionized the development of biologics. These therapies, including monoclonal antibodies, recombinant proteins, cell and gene therapies, and vaccines, offer innovative treatment options for a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. The unique nature of biologics necessitates extensive testing and evaluation through clinical trials, leading to an increased demand for clinical trial supplies.

Biologics are typically produced using complex manufacturing processes involving living cells or organisms. These processes require specialized facilities, equipment, and expertise to ensure the safety, efficacy, and quality of the final product. Clinical trials involving biologics require adequate supplies of these specialized manufacturing materials, including cell lines, culture media, growth factors, vectors, and other components essential for the production of biologic therapies.

Download Free Sample Report

Regulatory authorities have established rigorous standards for the approval of biologics due to their complex nature and potential impact on patient health. The demand for clinical trial supplies arises from the need to conduct well-designed trials that comply with regulatory guidelines and generate robust evidence for regulatory submissions. Biologic therapies often target specific patient populations, such as those with rare diseases or specific genetic profiles. Clinical trials involving these therapies require careful patient selection and enrollment processes to ensure the evaluation of treatment effectiveness in the targeted population.

Additionally, biologics are frequently used in combination therapies or personalized medicine approaches, where multiple therapies or treatment regimens are tailored to individual patients. Clinical trials investigating these complex treatment modalities require a comprehensive supply of various biologic agents, diagnostic tools, and supporting supplies to ensure accurate dosing, monitoring, and safety assessments.

Moreover, the rise of biosimilars, which are highly similar versions of already approved biologic therapies, has also contributed to the increased demand for clinical trial supplies. Biosimilars require clinical trials to establish similarity in terms of safety, efficacy, and quality compared to the reference biologic. These trials necessitate adequate supplies of both the biosimilar and the reference product for comparative evaluations.

Market Segmentation:

The global clinical trial supplies market can be segmented based on services, type, therapeutic areas, end user, region and competitive landscape. Based on services, the market can be categorized into manufacturing, packaging, labeling & blinding, logistics & distribution, storage & retention, comparator sourcing, and others. Based on type, the market is segmented into small molecule drugs, biologic drugs, and medical devices. Based on therapeutic areas, the market can be fragmented into oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, blood disorders, immunology, and other therapeutic disorders. Based on end user, the market is segmented into pharmaceutical companies, biotechnology companies, and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Market Players

Thermo Fisher Scientific Inc., Catalent Inc, Almac Group,    PRA Health Sciences, Piramal Pharma Solutions, Clinigen Group Plc, Eurofins Scientific SE, Parexel International Corporation, are some of the key players operating in the Global Clinical Trial Supplies Market.

Report Scope:

In this report, Global Clinical Trial Supplies Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Clinical Trial Supplies Market, By Services:
• Manufacturing
• Packaging Labeling & Blinding
• Logistics & Distribution
• Storage & Retention
• Comparator Sourcing
• Other
• Clinical Trial Supplies, By Type:
• Small Molecule drugs
• Biologics drugs
• Medical Devices  
• Clinical Trial Supplies, By Therapeutic Areas:
• Oncology
• CNS and Mental Disorders
• Cardiovascular diseases
• Digestive disorders
• Infectious Diseases
• Metabolic disorders
• Blood disorders
• Immunology
• Other therapeutic disorder
• Clinical Trial Supplies, By End User:
• Pharmaceutical
• Biotechnology companies
• Contract Research Organizations (CROs)
• Clinical Trial Supplies, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa

 Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trial Supplies Market.

Available Customizations:

With the given Market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]